0
Skip to Content
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
DONATE
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
DONATE
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
Back
DONATE
  • Medical Education Webinars,
  • Patient Videos & Webinars,
• 8/7/24

2021 RUNX1 Week Keynote Speaker: Dr. David Fajgenbaum

Dr. David Fajgenbaum, co-founder and CEO of the Castleman Disease Collaborative Network, discusses his personal battle with this rare disease that almost killed him several times, and his tireless research that led to the discovery of a life-saving treatment for himself and many other Castleman patients.

Previous

Module 4: Banking Stem Cells Today for the Possible Gene Editing Capabilities of Tomorrow

Next

Wanting (More) Children While Facing An Inherited Blood Cancer

You Might Also Like

Related Embedded Video Item Thumbnail RUNX1 Deficiency in Megakaryopoiesis: Discovering Therapeutics for RUNX1 Haploinsufficiency
Related Embedded Video Item Thumbnail Introduction to the RUNX1-FPD Sirolimus Pilot Study (6.24.24)
Related Embedded Video Item Thumbnail Neoplasias Hematológicas Hereditarias: No Tan Poco Frecuentes (September 2024)
Related Embedded Video Item Thumbnail Intro to PCOR - Defining it for the RUNX1-FPD Community
Related Embedded Video Item Thumbnail Neoplasias Hematológicas Hereditarias: No Tan Poco Frecuentes (July 2024)

Sign Up For Our Email List!

Enter your information below to receive the
latest RUNX1 news and updates!

Stay In Touch

Email RRP

Newsletter

Policies

Privacy Policy

Cookie Policy

Accessibility Statement

Site Resources

News & Updates

Calendar of Events

RRP Blog

DONATE
DONATE
SHOP
SHOP